Anti-RAF1 antibody
Specifications
| Product Cat#: | AB-06-3811 |
| Product type: | Primary antibody |
| Antigen: | RAF1 |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:1000-1:2000); Immunocytochemistry (1:50-1:200); Immunofluorescence |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal (JJ086-06) |
| Form: | Liquid |
| Buffer: | TBS (pH7.4), 1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Alternative names: | c Raf antibody |
| C-raf antibody | |
| C-Raf proto-oncogene, serine/threonine kinase antibody | |
| CMD1NN antibody | |
| Craf 1 transforming gene antibody | |
| cRaf antibody | |
| Craf1 transforming gene antibody | |
| EC 2.7.11.1 antibody | |
| kinase Raf1 antibody | |
| Murine sarcoma 3611 oncogene 1 antibody | |
| NS5 antibody | |
| Oncogene MIL antibody | |
| Oncogene RAF1 antibody | |
| OTTHUMP00000160218 antibody | |
| OTTHUMP00000207813 antibody | |
| OTTHUMP00000209389 antibody | |
| Protein kinase raf 1 antibody | |
| Proto-oncogene c-RAF antibody | |
| Raf 1 antibody | |
| Raf 1 proto oncogene serine/threonine kinase antibody | |
| RAF antibody | |
| Raf proto oncogene serine/threonine protein kinase antibody | |
| RAF proto-oncogene serine/threonine-protein kinase antibody | |
| RAF-1 antibody | |
| RAF1 antibody | |
| RAF1_HUMAN antibody | |
| Similar to murine leukemia viral (V-raf-1) oncogene homolog 1 antibody | |
| TRANSFORMING REPLICATION-DEFECTIVE MURINE RETROVIRUS 3611-MSV antibody | |
| v raf 1 murine leukemia viral oncogene homolog 1 antibody | |
| v-raf murine sarcoma viral oncogene homolog 1 antibody |
Show More
Target information
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2).
Provider
Erpantech Laboratory
